Biogen To Pay $22M To Resolve Drug Kickback Claims
Biogen Inc. will pay $22 million to resolve allegations that it illegally used two foundations to pay Medicare co-pays for patients taking the company's multiple sclerosis drugs, becoming the latest in...To view the full article, register now.
Already a subscriber? Click here to view full article